SHC Enzyme Variants for Higher Sclareolide Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing ambrox, a valuable aroma chemical, are inefficient and costly, particularly in the enzymatic conversion of homofarnesoic acid to sclareolide, which is then non-enzymatically converted to ambrox.
Innovation Solution
Development of variant squalene hopene cyclase (SHC) polypeptides with specific amino acid substitutions, such as V45L, Q54E, I278T, and T326S, which enhance the enzymatic conversion of homofarnesoic acid to sclareolide, a precursor for ambrox production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If wild-type squalene hopene cyclase is used to convert homofarnesoic acid to sclareolide, then the reaction can proceed, but the specific activity is very low (0.02 mU/mg protein) and production efficiency is poor
Solution Approach 1:
The patent applies parameter changes by modifying specific amino acid residues in the SHC enzyme sequence (positions V45, Q54, Q178, M184, V222, R249, I278, Y284, T326, R348, A574, A683) to optimize its catalytic activity for converting homofarnesoic acid to sclareolide. These sequence variations result in enzymes with significantly improved specific activity compared to wild-type SHC.
Solution Approach 2:
The patent applies local quality by making targeted modifications at specific positions in the enzyme's amino acid sequence rather than complete redesign. The substitutions are made at critical residues that influence substrate binding and catalysis, thereby locally optimizing the enzyme's function for high-efficiency sclareolide production.
2Productivity
If multiple amino acid substitutions are made in SHC to improve sclareolide production, then productivity increases, but the complexity of enzyme characterization and optimization increases
Solution Approach 1:
The patent applies segmentation by dividing the enzyme optimization into discrete, identifiable amino acid position modifications. Each substitution at specific positions (V45, Q54, Q178, etc.) can be independently analyzed and combined, allowing systematic optimization while maintaining manageable complexity through modular approach.
Solution Approach 2:
The patent applies partial action by making a limited set of targeted amino acid substitutions rather than comprehensive random mutagenesis. This selective approach optimizes productivity while avoiding the excessive complexity that would result from exhaustive screening of all possible mutations.
3Productivity
If chemical methods (chromic acid, permanganate, H2O2, ozone) are used to oxidize sclareol to sclareolide, then the conversion can be achieved, but the methods are costly and involve harmful chemicals
Solution Approach 1:
The patent replaces harsh chemical oxidation methods (chromic acid, permanganate, H2O2, ozone) with a biological catalytic system using engineered SHC enzyme. This substitution eliminates toxic chemicals while maintaining efficient conversion of sclareol to sclareolide through enzymatic oxidation, thereby removing harmful factors from the process.
Solution Approach 2:
The engineered SHC enzyme acts as an intermediary catalyst that facilitates the oxidation of sclareol to sclareolide under milder conditions. This biological intermediary replaces direct chemical oxidation, reducing toxicity and cost while maintaining high conversion efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The variant SHC polypeptides significantly increase the production of sclareolide, providing a more efficient and cost-effective pathway for ambrox synthesis.
Implementation Method 1
variants of squalene hopene cyclase (SHC) are provided for enzymatically converting homofarnesoic acid to sclareolide
Implementation Method 2
catalysis of ambrox is a secondary reaction... SHC naturally catalyzes the cyclization of squalene to hopane
Data Source
AI summary
Variants of squalene hopene cyclase (SHC) are provided for enzymatically converting homofarnesoic acid to sclareolide, which can be non-enzymatically converted to ambrox.